HH Biotechnology Holdings Company
HH Biotechnology Holdings Company engages in health and green industries. It focuses on planting and supplying macadamia nuts for use in foods, cooking oils, healthy products, toiletries, and cosmetics. The company was formerly known as Great China International Holdings, Inc. and changed its name to HH Biotechnology Holdings Company in August 2016. HH Biotechnology Holdings Company was incorpora… Read more
HH Biotechnology Holdings Company (HHBT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2016: 0.085x
Based on the latest financial reports, HH Biotechnology Holdings Company (HHBT) has a cash flow conversion efficiency ratio of 0.085x as of September 2016.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.52 Million) by net assets ($29.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
HH Biotechnology Holdings Company - Cash Flow Conversion Efficiency Trend (2012–2015)
This chart illustrates how HH Biotechnology Holdings Company's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
HH Biotechnology Holdings Company Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of HH Biotechnology Holdings Company ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fashion Bel Air S.A
PA:ALFBA
|
0.029x |
|
Universal Media Group Inc
PINK:UMGP
|
0.001x |
|
Healixa Inc
PINK:EMOR
|
N/A |
|
EGUVF
PINK:EGUVF
|
-0.024x |
|
BAKRIE SUMATERA PL
BE:OSW
|
N/A |
|
Hoshi Resource Corp.
V:HRC-P
|
-0.005x |
|
BlackRock American Income Trust Ord
LSE:BRAI
|
N/A |
|
JPMORGAN EMERGING EUROPE MIDDLE EAST & AFRICA SECURITIES PLCc
LSE:JEMA
|
-0.007x |
Annual Cash Flow Conversion Efficiency for HH Biotechnology Holdings Company (2012–2015)
The table below shows the annual cash flow conversion efficiency of HH Biotechnology Holdings Company from 2012 to 2015.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2015-12-31 | $28.36 Million | $3.57 Million | 0.126x | +43.04% |
| 2014-12-31 | $19.14 Million | $1.69 Million | 0.088x | +24.96% |
| 2013-12-31 | $24.01 Million | $1.69 Million | 0.070x | +131.31% |
| 2012-12-31 | $25.12 Million | $765.57K | 0.030x | -- |